VIVORYON THERAPEUTICS AG has a total of 18 patent applications. It increased the IP activity by 200.0%. Its first patent ever was published in 2017. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are Hoffmann-La Roche Inc, LEUKOSITE INC and Shanghai hengrui pharmaceutical co ltd.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 3 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | Israel | 2 | |
#5 | Republic of Korea | 2 | |
#6 | Singapore | 2 | |
#7 | United States | 2 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Russian Federation | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Heterocyclic compounds | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Schilling Stephan | 9 |
#2 | Heiser Ulrich | 5 |
#3 | Gillies Stephen | 5 |
#4 | Kleinschmidt Martin | 5 |
#5 | Hettmann Thore | 5 |
#6 | Sommer Robert | 5 |
#7 | Schlenzig Dagmar | 4 |
#8 | Buchholz Mirko | 4 |
#9 | Rahfeld Jens-Ulrich | 4 |
#10 | Ramsbeck Daniel | 4 |
Publication | Filing date | Title |
---|---|---|
EP3750878A1 | Heteroaromatic inhibitors of astacin proteinases |